Page 148 - Biomedical Engineering News Today

Type 1 diabetes used to be known as a disease that develops in younger teens and kids. But according to some experts, that is not the case.

By offering a subscription model for dentists, a new start-up by the name of Implant Club might disrupt an industry that has been sitting comfortably for a number of decades.

Vidal will serve as the Rachleff University Professor at Penn with joint appointments in two schools.

Northwestern University-led researchers have created the first highly mature neurons from human induced pluripotent stem cells (iPSCs) a feat that opens new opportunities for medical research and potential transplantation therapies for neurodegenerative diseases and traumatic injuries.

Cellulose nanocrystals are bio-based nanomaterials that have been derived from natural resources like plant cellulose.

To help the estimated 1.45 million Americans living with type 1 diabetes better manage their blood sugar levels, Oregon Health & Science University is combining the power of an artificial

Experimental setup for U-M’s iRAI system (metal box on left) using a lard "phantom" (cylinder at center) that approximates the human body. Image credit: U-M Optical Imaging Laboratory Study: Real-time, volumetric imaging of radiation dose delivery deep into the liver during cancer treatment (DOI

You are reading this because of materials. Whether you are perusing this article on an electronic device driven by a semiconductor chip or via a paper printout, the ability to read these words is in a large part due to innovative materials research that led to a product in use in society.

Much like a fresh set of eyes, a small pen-shaped device is showing surgeons a more accurate way to treat cancer and heart disease. The device uses new technology developed at UC Davis to scan and illuminate unhealthy tissue in real time so it can be removed. For use during surgery, the technology is called Fluorescence Lifetime Imaging (FLIm). Surgeons use the device to scan tissue, which will alter the fluorescence if metabolic abnormalities or cancerous cells are present. This is because tumo...

Optometrists, ophthalmologists and their patients will benefit from new, high-tech tools to detect glaucoma at its earliest stages thanks to a startup that will commercialize smart contact lenses developed at Purdue University.